Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03001765 · ClinicalTrials.gov registry record · NA
Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia
A NA study of Suspected Arrhythmia, sponsored by St Elizabeth Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT03001765 is a NA study of Suspected Arrhythmia that has completed, run by St Elizabeth Healthcare. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03001765, a NA study of Suspected Arrhythmia, has completed, sponsored by St Elizabeth Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypothesis: Patients that were previously discharged from the emergency department with a subsequent non-diagnostic 30 day external patch monitor for suspected arrhythmia will benefit from early Reveal LINQ™ Insertable Cardiac Monitoring System placement. Primary Study Objectives: To evaluate the outcome of an intensive monitoring strategy (patients with a negative 30 day SEEQ™ Mobile Cardiac Telemetry (MCT) System result are purposed over for a Reveal LINQ™ Insertable Cardiac Monitoring System) in patients with suspected but no previously documented arrhythmias that result in a clinically actionable event.
Conditions Studied
Interventions
- OTHER Intensive Monitoring Strategy: Reveal LINQ™ Insertable Cardiac Monitoring System".
Study Locations (1)
Kentucky
- St. Elizabeth Healthcare - Edgewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03001765
The ClinicalTrials.gov registry entry for NCT03001765 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St Elizabeth Healthcare, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Suspected Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which Intensive Monitoring Strategy: Reveal LINQ™ Insertable Cardiac Monitoring System". is the first listed.
NCT03001765 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT03001765 about?
NCT03001765 is a clinical study titled "Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia". Hypothesis: Patients that were previously discharged from the emergency department with a subsequent non-diagnostic 30 day external patch monitor for suspected arrhythmia will benefit from early Reveal LINQ™ Insertable Cardiac Monitoring System placement. Primary Study Objectives: To evaluate the...
What is the current status of trial NCT03001765?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2016-12. Estimated completion is 2018-09.
What conditions does trial NCT03001765 study?
This clinical trial studies the following conditions: Suspected Arrhythmia.
What interventions are being tested in trial NCT03001765?
The interventions under investigation include: Intensive Monitoring Strategy: Reveal LINQ™ Insertable Cardiac Monitoring System". (OTHER).
Who is sponsoring clinical trial NCT03001765?
This trial is sponsored by St Elizabeth Healthcare, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03001765 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.